Email Address
Please enter your official email address
We notice that your permissions preference cookie is missing. Please enter your email address so we can determine if you need to complete a permission form or verify that you have already completed this form. Receiving permission from our users is an important part of our compliance with international privacy regulations. Your email address will not be shared without your permission. Please refer to our
privacy policy
for information on how we protect your personal information.
Welcome to AdisInsight
We need some information from you before you start using the platform.
This information will allow us to better understand how AdisInsight is being used.
It does not require or replace the individual login accounts that many of you use to save searches and create email alerts.
Protecting your personal information is important.
That is why AdisInsight collects the minimum amount of information necessary to enable functionality, report usage, and contact you with information about AdisInsight.
For further information on how we protect and process your personal information, please refer to our
privacy policy.
Terms of Service
By accessing or using the AdisInsight platform you agree to the terms of use.
Please select terms of use
How much you and your colleagues use AdisInsight often determines if your organization will continue paying to provide access to the platform.
The number of times you access AdisInsight, the number of searches you performed, and the number of profiles you viewed will be provided to your organization both in aggregate with other users and individually by your email address.
You have the right to opt-out of sharing your email address with your organization but doing so may negatively affect your organization’s decision to renew their subscription to AdisInsight. If you opt-out your email will still be collected for registration purposes.
Please choose your email permissions
Get more from AdisInsight
Keep up to date with all things AdisInsight by signing up to receive our product bulletin, which includes related content from Springer Nature such as white papers, product news, industry commentaries, and webinar invites, straight to your inbox. Unsubscription is always possible via email.
Access leading, evidence-based scientific and market information on drugs in commercial development worldwide. Drug and cell-based products are tracked across all therapeutic areas and throughout the entire development process, from discovery to launch.
Profiles include:
Key development milestones
Development status and history
Drug properties
Chemical synopses
Pharmacokinetics data
Pharmacodynamics data
Company agreements
Trial landscape and details
Related safety reports
Patent information
Related drugs
Drug limitations
Immunogenicity
Trials
Quickly identify the clinical trials being performed to advance these drugs through international regulatory pathways, with coverage of both international and observational trials.
Profiles include:
Phase of trial and current status
Trial purpose, focus and design
Primary and other endpoints
Diseases and subjects treated
Inclusion and exclusion criteria
Trial identifiers
Organizations involved
Initiation, completion and end dates
Interventions
Study center and investigator details
Trial history
Outcomes and results
Related authors
Safety Reports
The most comprehensive and reliable worldwide resource for pharmacovigilance literature monitoring, AdisInsight provides fast and easy access to published adverse drug reaction (ADR) case reports, drug safety studies and regulatory news covering all drugs and therapeutic areas, updated daily.
Records provide:
Easy identification of serious, overdose, interaction and first published case reports
Expert summaries of Individual Case Safety Reports (ICSRs) that comply with CIOMS II guidelines for Periodic Safety Update Reports (PSURs)
WHO contextual adverse event data for first published case reports
Full citation details with links to the full-text where available, to support further research
Reports dating back to 1982
Deals
Review concise summaries of purchases and acquisitions, joint ventures, and agreements for licensing, R&D, development, manufacturing, distribution and marketing with deal values given, where available. AdisInsight can help you to keep up with the ever-changing landscape of drug development, to identify opportunities for investment, business development and collaboration, and benchmark relative deal values and terms for your own technologies.
Profiles include:
Type of agreement
Date of agreement
Organizations involved
Drugs involved
Indications involved
Summary of the deal
Deal value
Patents
Patents is an extension of Drugs providing key information about the global parents and market exclusivities protecting a specific drug. For an AdisInsight Drug profile there is a corresponding Drug Patent Profile that presents the global patents and market exclusivities that are protecting that drug. Patent information is presented in summary tables to facilitate quick and easy understanding of key patent information impacting a drug landscape and determining the timing of generic entry.
